MATTES GLENN R. (President and CEO) sold 75.0% of their position (30K shares) of TFF PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $459.9K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/29/2020ACC: 0001213900-20-045177
DirectorOfficer· President and CEO
Since Oct 2019
-30K
Net shares
Net seller
$459.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
30K acquired · 60K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+30K
Price / share
$2.50
Trade value
$75K
% of position
300.0%
12/23/2020
10K→40K
Common Stock
Direct
Shares
−30K
Price / share
$15.33
Trade value
$459.90K
% of position
75.0%
12/23/2020
40K→10K
Total
Net shares
+0.00
Net value
-$384.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/23/2020 | M · Option Exercise | +30K | $2.50 | $75K | 300.0% | 10K | 40K |
| Common Stock Direct | 12/23/2020 | S · Sale | −30K | $15.33 | $459.90K | 75.0% | 40K | 10K |
| Total | +0.00 | -$384.90K | ||||||
Derivative Transactions1
Stock Options (Right to Buy)
Direct
Converts to
Common Stock
30K shares
Shares
−30K
Strike price
2.5
Held after
1.07M
Exercisable
—
12/23/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) Direct | Common Stock30K shares | 12/23/2020 | M · Option Exercise | −30K | 2.5 | — | 1.07M |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned10K
Total
10K indirect10K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 10K | Indirect |
| Total | 10K | 10K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported